title: Multi-link Vision and MiniVision stent registry in Asian patients with coronary artery disease: a prospective, multi-center study.
abstract: BACKGROUND
  Recent studies have showed that the fine mesh stents are associated with a significant reduction in both clinical and angiographic re-stenosis of the coronary arteries. To maintain a very satisfactory radio-opacity using the stents, Guidant of the USA has designed a new type of bare metal stents (BMS)-Multi-link (ML) Vision/ML MiniVision stents. The clinical outcomes of Asian patients with coronary artery disease (CAD) after implanting the Multi-link Vision or MiniVision stent were investigated in this study.
  
  
  METHODS
  An observational, prospective, multi-center, non-randomized post marketing registry was conducted to demonstrate the efficacy of the BMS-ML Vision/ML MiniVision stents. The primary end point of the registry was clinical target lesion revascularization (TLR) at a 6-month follow-up. The major secondary end points included the rate of major adverse cardiac events (MACE) and serious adverse events (SAE) in hospital and at 6 months; and the rate of clinical TLR as a function of the type of angina. A total of 429 Asian people with 449 lesions from 14 centers were selected for this study. The average reference diameter of the lesions was (3.0 +/- 0.5) mm, and the mean length was (15.7 +/- 5.0) mm.
  
  
  RESULTS
  The successful rate of the procedure was 99.3%. Twenty-five percent of the lesions were treated by direct stenting without pre-dilation. Eighty-six percent of the lesions were implanted with ML Vision stent. After the 6-month follow-up, the rate of clinical TLR was 1.4%. The MACE, SAE and target vessel revascularization (TVR) were 6.8%, 3.5% and 1.4% respectively.
  
  
  CONCLUSIONS
  The current registry showed the excellent 6-month clinical outcomes of ML Vision/ML MiniVision stents in Asian patients with CAD.
authors.affiliation: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430063, China.
authors.forename: Ya-Wei
authors.initials: YW
authors.lastname: Xu
authors.forename: Yi-Dong
authors.initials: YD
authors.lastname: Wei
authors.forename: Kai
authors.initials: K
authors.lastname: Tang
authors.forename: Yan-Qing
authors.initials: YQ
authors.lastname: Chen
authors.forename: Wei-Ming
authors.initials: WM
authors.lastname: Li
authors.forename: Xue-Jing
authors.initials: XJ
authors.lastname: Yu
authors.forename: Yong-Wen
authors.initials: YW
authors.lastname: Qin
authors.forename: Guo-Xian
authors.initials: GX
authors.lastname: Qi
authors.forename: Peng
authors.initials: P
authors.lastname: Qu
authors.forename: Yu-Qing
authors.initials: YQ
authors.lastname: Hou
authors.forename: Ashok
authors.initials: A
authors.lastname: Jain
authors.forename: Parvez
authors.initials: P
authors.lastname: Grant
authors.forename: Gudapati
authors.initials: G
authors.lastname: Ramesh
authors.forename: Basavappa
authors.initials: B
authors.lastname: Ramesh
authors.forename: Chumpol
authors.initials: C
authors.lastname: Piamsomboon
authors.forename: Srun
authors.initials: S
authors.lastname: Kuanprasert
authors.forename: Hyeon-Cheol
authors.initials: HC
authors.lastname: Gwon
authors.forename: Yoon Haeng
authors.initials: YH
authors.lastname: Cho
authors.forename: Haizal Haroon
authors.initials: HH
authors.lastname: Kamar
authors.forename: Cong-Xin
authors.initials: CX
authors.lastname: Huang
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D002858:Chromium Alloys; D003327:Coronary Disease / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012042:Registries; D015607:Stents
chemical_list: D002858:Chromium Alloys